Icon - Menu open Search

Board

Our Board’s mission is to develop strategic priorities for Canadian cancer research funding, track the cancer research investment, and reinforce the value of cancer research by strengthening its research community through funding partnerships, scientific conferences, and reports.

Representatives of patients and families as well as cancer research funding organizations make up the CCRA Board.

Paula Robson Chair

Paula J. Robson, PhD, is the Scientific Director, Cancer Research and Analytics and Scientific Director, Cancer Strategic Clinical Network Cancer Care Alberta, Alberta Health Services

 

 

View Past Chairs
resource highlights 02

Patient/Family Representatives

  • Ms. Ruth Ackerman
  • Dr. Don Desserud

Organizational Representatives

  • Dr. Judy Bray, Vice President, Research, Canadian Cancer Society
  • Dr. Lakshmi Krishnan, Director General, Human Health Therapeutics, National Research Council
  • Dr. Catalina Lopez-Correa, Chief Scientific Officer, Genome Canada
  • Dr. Anne-Marie Mes-Masson, Director, Réseau de recherche sur le cancer, Fonds de recherche du Québec – Santé
  • Dr. Paul O’Connell, Manager, Medical and Scientific Engagement, The Leukemia & Lymphoma Society of Canada
  • Dr. Dajan O’Donnell, Director, Scientific Affairs and Partnerships, Cancer Research Society
  • Mr. Rami Rahal, Vice President, Cancer Systems, Performance and Innovation, Canadian Partnership Against Cancer
  • Dr. Stephen Robbins, Scientific Director, CIHR Institute of Cancer Research
  • Dr. Paula Robson, Scientific Director – Cancer Research, Cancer Care Alberta & Cancer Strategic Clinical Network
  • Mr. Patrick Sullivan, Board of Directors, Childhood Cancer Canada
  • Dr. Jon Tonita, President & CEO, Saskatchewan Cancer Agency, representing the Canadian Association of Provincial Cancer Agencies
  • Dr. Neil Watkins, Director, Research Institute in Oncology and Hematology; Chief of Research, CancerCare Manitoba
  • Dr. Christine Williams, Deputy Director, Ontario Institute for Cancer Research
  • Dr. Jim Woodgett, President and Scientific Director, The Terry Fox Research Institute